New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

$300 Hep C Cure Just as Good as $84,000 Alternative

Non-profit organization DNDi has developed a low-cost hepatitis C treatment that stands to benefit 71 million people.

Protesters / Image: Josep Lago
Protesters / Image: Josep Lago

A recent article from The Guardian had good news for the 71 million people affected by hepatitis C, the blood-borne viral infection that causes 400,000 deaths a year. The non-profit Drugs for Neglected Diseases initiative (DNDi) has teamed up with Egypt’s Pharco Pharmaceuticals to create a two-pill treatment for the disease that’s expected to cost just $300.

The drugs, ravidasvir and sofosbuvir, are a welcome alternative to versions from Gilead and AbbVie, which can cost up to $84,000. The DNDi reported that the new treatment cured 97% of patients within 12 weeks.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts